NCT07887477Active, not recruiting
Different Diets in Different Diabetes - 4DI PLAN'EAT Pilot Study
"Different Diets in Different Diabetes" - Diete Diverse Per Diversi Diabetici
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn whether a diet adapted to a person's cultural background, combined with a supervised physical activity programme, improves blood sugar control better than standard dietary advice in adults with type 2 diabetes. Participants come from four cultural backgrounds (Italian, Eastern European, North African, and South Asian) and live in Italy. The main questions it aims to answer are: * Does a culturally adapted Mediterranean diet combined with structured physical activity lower glycated haemoglobin (HbA1c) more than standard dietary advice? * Does it reduce body weight, body mass index and waist circumference more than standard dietary advice? Researchers will compare participants who receive the culturally adapted diet and the supervised walking programme with participants who receive standard dietary and behavioural advice, to see whether the adapted approach improves blood sugar control and body measurements more. Participants in both groups continue to receive their diabetes medication, adjusted as needed according to clinical guidelines. Participants will: * Attend medical visits at the start of the study and after 3, 6 and 12 months, where body weight, waist circumference, blood pressure and heart rate are measured and blood test results are reviewed; * Meet a dietitian at the start of the study and after 3, 6 and 12 months; * Complete questionnaires on perceived stress, sleep quality, mood and general health at each medical visit; * Provide a finger-prick dried blood spot sample and a saliva sample at the beginning and end of each medical visit; * If they choose to be assigned to the culturally adapted group, follow a personalised diet built around traditional dishes from their country of origin and take part in supervised group walks at least once a week for 12 months.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 101 (actual)
- First submitted
- 7 Oct 2026
- Start date
- 3 Jun 2024
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- University of Bologna
- Diseases
- Type 2 diabetes
- NCT number
- NCT07887477
What you commit to
- Study type: Interventional
- Participants enrolled: 101
- From 3 Jun 2024 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous bariatric surgery
Other illness
- Type 1 diabetes mellitus
- Active malignancy
Lab values
- Chronic kidney disease (GFR \< 30 ml/min), heart failure (NYHA class 3 or 4), or hepatic failure
Other
- Inability or unwillingness to participate in a structured physical activity program
- Adherence to a weight-loss diet in the 3 months preceding the study
- Use of illicit or abused substances in the 3 months preceding the study
Who the study is looking for
- Age between 18 and 70 years at the time of signing the informed consent
- Belonging to one of the following ethnic groups: Italian, Eastern European, North African, or from the Indian subcontinent (India, Pakistan, Bangladesh, Sri Lanka)
- Diagnosis of type 2 diabetes mellitus
- Understanding of the Italian or English language
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| U.O.C. Endocrinologia e Prevenzione e Cura del Diabete, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola Coordinator of this site? Confirm its status | Bologna | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.